4b.03: Empagliflozin Reduces Systolic Blood Pressure in Dipper and Non-dipper Patients with Type 2 Diabetes and Hypertension.

OBJECTIVE To assess changes in systolic blood pressure (SBP) with empagliflozin in patients with type 2 diabetes and hypertension (defined as mean seated office SBP 130-159 mmHg and diastolic BP 80-99 mmHg) categorised as dippers or non-dippers. DESIGN AND METHOD In a subgroup analysis of patients who received empagliflozin 10 mg, empagliflozin 25 mg or… CONTINUE READING